Medicine and Dentistry
Erlotinib
100%
Lung Adenocarcinoma
100%
Idiopathic Interstitial Pneumonia
100%
Gefitinib
25%
Pulmonary Toxicity
25%
Non Small Cell Lung Cancer
12%
Epidermal Growth Factor Receptor Kinase Inhibitor
12%
Symptom
12%
Acute Lung Injury
12%
Acute Respiratory Failure
12%
Gamma Urogastrone
12%
Patient History of Chemotherapy
12%
Chemotherapy Regimens
12%
Interstitial Lung Disease
12%
English (Language)
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Adenocarcinoma
100%
Interstitial Pneumonia
100%
Erlotinib
100%
Gefitinib
25%
Lung Toxicity
25%
Symptom
12%
Acute Lung Injury
12%
Non Small Cell Lung Cancer
12%
Epidermal Growth Factor Receptor Kinase Inhibitor
12%
Gamma Urogastrone
12%
Patient History of Chemotherapy
12%
Chemotherapy Regimens
12%
Acute Respiratory Failure
12%
Interstitial Lung Disease
12%